Wolfgang Korte
Overview
Explore the profile of Wolfgang Korte including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
925
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Woelfel S, Junker D, Bergamin I, Meyer-Herbon P, Stillhard R, Graf N, et al.
Vaccines (Basel)
. 2024 Nov;
12(11).
PMID: 39591144
Background: Patients with chronic liver disease (CLD) have impaired vaccine immunogenicity and an excess risk of severe COVID-19. While variant-adapted COVID-19 mRNA vaccines are recommended for vulnerable individuals, their efficacy...
2.
Woelfel S, Dutschler J, Junker D, Konig M, Graf N, Krieger C, et al.
Aliment Pharmacol Ther
. 2024 Oct;
61(2):299-312.
PMID: 39468971
Background: Variant-adapted COVID-19 vaccines are recommended for patients with inflammatory bowel disease (IBD). However, many patients rely on pre-existing immunity by original vaccines or prior infections. Aim: To assess whether...
3.
Sweis N, Jorgensen J, Zeng J, Choo-Kang C, Zapater J, Bedu-Addo K, et al.
Int J Obes (Lond)
. 2024 Oct;
49(2):278-285.
PMID: 39420085
Objective: This cross-sectional study aims to assess the associations between serum leptin, adiponectin, leptin-to-adiponectin ratio (L/A ratio), and metabolic syndrome (MS) and HOMA-IR in five African-origin populations: Ghana, South Africa,...
4.
Woelfel S, Dutschler J, Junker D, Konig M, Leinenkugel G, Graf N, et al.
Vaccines (Basel)
. 2024 Jul;
12(7).
PMID: 39066413
Recently updated COVID-19 mRNA vaccines encode the spike protein of the omicron subvariant XBB.1.5 and are recommended for patients with inflammatory bowel disease (IBD) on immunosuppressive treatment. Nonetheless, their immunogenicity...
5.
Lier H, Annecke T, Girard T, Pfanner G, Korte W, Tiebel O, et al.
Transfus Med Hemother
. 2023 Dec;
50(6):547-558.
PMID: 38089489
Background: Peripartum haemorrhage (PPH) is a potentially life-threatening complication. Although still rare, the incidence of peripartal haemorrhage is rising in industrialised countries and refractory bleeding remains among the leading causes...
6.
Woelfel S, Dutschler J, Konig M, Dulovic A, Graf N, Junker D, et al.
Aliment Pharmacol Ther
. 2023 Aug;
58(7):678-691.
PMID: 37571863
Background: Vaccine-elicited immune responses are impaired in patients with inflammatory bowel disease (IBD) treated with anti-TNF biologics. Aims: To assess vaccination efficacy against the novel omicron sublineages BQ.1.1 and XBB.1.5...
7.
Haslinger C, Korte W
Transfus Med Hemother
. 2023 Feb;
50(1):1.
PMID: 36818777
No abstract available.
8.
Duque P, Korte W
Transfus Med Hemother
. 2023 Feb;
50(1):10-17.
PMID: 36818773
Background: Major hemorrhage is one of the main causes of preventable mortality in either severe trauma, high-risk surgical patient, or the obstetric population. As underlined by the cell-based coagulation model,...
9.
Brun R, Hothorn T, Eigenmann E, Frevert M, Zimmermann R, Korte W, et al.
Transfus Med Hemother
. 2023 Feb;
50(1):2-9.
PMID: 36818769
Background: Postpartum hemorrhage is a leading cause of maternal morbidity and mortality worldwide. Contradictory information exists regarding the relevance of prepartum platelet count on postpartum hemorrhage. We have shown prepartum...
10.
Burgi J, Rosslein M, Nolte O, Wick P, Garcia Boy R, Stranders S, et al.
Front Cardiovasc Med
. 2022 Dec;
9:1053790.
PMID: 36531721
Importance: Elderly patients, especially men, are at risk of increased morbidity from coronavirus disease 2019 (COVID-19). Long-term data on troponin I levels in longitudinal observational studies of outpatients with mild...